ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Nephrology Self-Assessment Program (NephSAP)

nephSAP: Volume 11


74 1.6MB It is well over 50 years since pioneers in pediatric nephrology such as Reneé Habib (1), Bob Vernier (2), Clark West (3), and others initiated work that would differentiate pediatric from adult nephrology. And it is roughly 40 years since the Inter
NephSAP

Volume 11, Number 1, January 2012

Pediatric Nephrology

Howard Trachtman, MD, and Debbie Gipson, MD
AMA PRA Category 1 Credits™

It is well over 50 years since pioneers in pediatric nephrology such as Reneé Habib (1), Bob Vernier (2), Clark West (3), and others initiated work that would differentiate pediatric from adult nephrology. And it is roughly 40 years since the Inter...




74 4MB Much like changing the nomenclature from ARF to AKI, the clinical scenario formerly known as malignant hypertension is now referred to as acute severe hypertension.
NephSAP

Volume 11, Number 2, March 2012

Hypertension

Raymond R. Townsend, MD, and Aldo J. Peixoto, MD
AMA PRA Category 1 Credits™

Much like changing the nomenclature from ARF to AKI, the clinical scenario formerly known as malignant hypertension is now referred to as acute severe hypertension....




105 2.3MB Current treatment strategies for glomerular diseases include high-dose glucocorticoids and cytotoxic agents such as cyclophosphamide, mycophenolate mofetil, and azathioprine.
NephSAP

Volume 11, Number 3, May 2012

Glomerular, Vascular, and Tubulointerstitial Diseases

Richard J. Glassock, MD, and Patrick Nachman, MD
AMA PRA Category 1 Credits™

Current treatment strategies for glomerular diseases include high-dose glucocorticoids and cytotoxic agents such as cyclophosphamide, mycophenolate mofetil, and azathioprine....




82 3.3MB A simplified version of gastrointestinal physiology for the nephrologist would state that the gastrointestinal tract simply absorbs everything presented to it in the lumen so that the kidneys can sort it out.
NephSAP

Volume 11, Number 4, July 2012

Disorders of Divalent Ions, Renal Bone Disease, and Nephrolithiasis

Stanley Goldfarb, MD and Kevin Martin, MBBCh
AMA PRA Category 1 Credits™

A simplified version of gastrointestinal physiology for the nephrologist would state that the gastrointestinal tract simply absorbs everything presented to it in the lumen so that the kidneys can sort it out....




86 3.6MB There are encouraging developments on the diabetes front in the United States. The cardiovascular mortality is falling significantly (1) and the incidence of ESRD due to type 2 diabetes is decreasing over the recent years.
NephSAP

Volume 11, Number 5, September 2012

Diabetic Kidney Disease

Kumar Sharma, MD, Scott C. Thomson, MD, and Stanley Goldfarb, MD
AMA PRA Category 1 Credits™

There are encouraging developments on the diabetes front in the United States. The cardiovascular mortality is falling significantly (1) and the incidence of ESRD due to type 2 diabetes is decreasing over the recent years....




107 2.3MB When hemodialysis became a maintenance treatment for ESRD in the early 1960s (1,2), dialysis devices necessitated 10- to 12-hour sessions applied mostly twice a week, to allow a minimal control of uremia.
NephSAP

Volume 11, Number 6, November 2012

End-Stage Renal Disease and Dialysis

Rajnish Mehrotra, MD and Rajiv Agarwal, MD
AMA PRA Category 1 Credits™

When hemodialysis became a maintenance treatment for ESRD in the early 1960s (1,2), dialysis devices necessitated 10- to 12-hour sessions applied mostly twice a week, to allow a minimal control of uremia....